← Back to Search

Behavioural Intervention

Lifestyle Intervention for Cancer Prevention

N/A
Recruiting
Led By Belinda Reininger, DrPH
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve an existing intervention program in Cameron and Hidalgo counties by adding new elements. These include education on the risks of alcohol and its link to cancer, as well as creating training

Who is the study for?
This trial is for residents of Cameron and Hidalgo counties who have not participated in the TSSC program before. It's aimed at underserved and rural populations, focusing on enhancing cancer prevention behaviors.
What is being tested?
The study tests an enhanced version of the TSSC curriculum by adding education about alcohol risks related to cancer and training to address social factors that affect cancer prevention practices.
What are the potential side effects?
Since this intervention involves educational modules and training rather than medical treatments, there are no direct side effects like those associated with medications or procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced TSSC curriculumExperimental Treatment1 Intervention
Group II: Original TSSC curriculumActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
937 Previous Clinical Trials
336,931 Total Patients Enrolled
2 Trials studying Cancer Prevention
3,554 Patients Enrolled for Cancer Prevention
Cancer Prevention Research Institute of TexasOTHER
52 Previous Clinical Trials
98,444 Total Patients Enrolled
1 Trials studying Cancer Prevention
1,554 Patients Enrolled for Cancer Prevention
Belinda Reininger, DrPHPrincipal InvestigatorThe University of Texas Health Science Center, Houston
2 Previous Clinical Trials
650 Total Patients Enrolled
~222 spots leftby Mar 2025